BSE Circulars (17020)
Bombay Stock Exchange circulars covering trading rules, listing requirements, compliance guidelines, market operations, and regulatory changes for market participants.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces securities entering, exiting, and continuing in Short Term ASM framework effective January 08, 2026. | |||||||||||||||
BSE announces securities entering, exiting, and continuing in Short Term ASM framework effective January 08, 2026.
| |||||||||||||||
BSE circular listing securities entering, exiting, and moving between stages in the Short Term Additional Surveillance Measure (ST-ASM) … | |||||||||||||||
BSE circular listing securities entering, exiting, and moving between stages in the Short Term Additional Surveillance Measure (ST-ASM) framework effective January 08, 2026.
| |||||||||||||||
Modern Diagnostic & Research Centre Limited equity shares to be transferred from Trade for Trade segment (MT Group) to Rolling segment (M … | |||||||||||||||
Modern Diagnostic & Research Centre Limited equity shares to be transferred from Trade for Trade segment (MT Group) to Rolling segment (M Group) effective January 21, 2026.
| |||||||||||||||
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED (Scrip Code: 544673) equity shares will be transferred from Trade for Trade segment (MT Group) … | |||||||||||||||
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED (Scrip Code: 544673) equity shares will be transferred from Trade for Trade segment (MT Group) to Rolling segment (M Group) effective January 21, 2026.
| |||||||||||||||
Trading in equity shares of MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED (Scrip Code: 544673) will be transferred from Trade for Trade … | |||||||||||||||
Trading in equity shares of MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED (Scrip Code: 544673) will be transferred from Trade for Trade segment (MT Group) to Rolling segment (M Group) effective January 21, 2026.
| |||||||||||||||
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED equity shares to be transferred from Trade for Trade segment (MT Group) to Rolling segment (M … | |||||||||||||||
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED equity shares to be transferred from Trade for Trade segment (MT Group) to Rolling segment (M Group) effective January 21, 2026.
| |||||||||||||||
BSE revises price bands for 23 scrips ranging from 2% to 20%, effective January 8, 2026, impacting daily trading limits for affected … | |||||||||||||||
BSE revises price bands for 23 scrips ranging from 2% to 20%, effective January 8, 2026, impacting daily trading limits for affected securities.
| |||||||||||||||
NATCO Pharma provides clarification on ongoing litigation news, while Cipla addresses USFDA Form 483 inspectional observations at supply … | |||||||||||||||
NATCO Pharma provides clarification on ongoing litigation news, while Cipla addresses USFDA Form 483 inspectional observations at supply partner Pharmathen's Greece facility.
| |||||||||||||||
NATCO Pharma clarifies ongoing litigation with no current material impact, while Cipla addresses USFDA Form 483 observations at partner … | |||||||||||||||
NATCO Pharma clarifies ongoing litigation with no current material impact, while Cipla addresses USFDA Form 483 observations at partner facility Pharmathen manufacturing Lanreotide Injection.
| |||||||||||||||
Three companies provide clarifications to BSE regarding increased volume/price movements in their securities, stating no undisclosed … | |||||||||||||||
Three companies provide clarifications to BSE regarding increased volume/price movements in their securities, stating no undisclosed material information and attributing movements to market conditions.
| |||||||||||||||